Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients.
Karaaslan Z, Kurtuncu M, Akcay Hİ, Gunduz T, Altunrende B, Turkoglu R, Eraksoy M, Ulusoy C, Yilmaz V, Tüzün E. Karaaslan Z, et al. Among authors: altunrende b. Eur Neurol. 2022;85(1):69-71. doi: 10.1159/000517770. Epub 2021 Aug 2. Eur Neurol. 2022. PMID: 34340233 Free article. No abstract available.
Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis.
Boz C, Terzi M, Özer B, Turkoglu R, Karabudak R, Efendi H, Soysal A, Sevim S, Altintas A, Kurne A, Akçalı A, Akman G, Yüceyar N, Balcı BP, Ekmekci Ö, Karahan SZ, Demirkıran M, Altunrende B, Turan ÖF, Gökçen GözübatıkÇelik, Kale N, Köseoğlu M, Ozakbas S. Boz C, et al. Among authors: altunrende b. Mult Scler Relat Disord. 2019 Nov;36:101376. doi: 10.1016/j.msard.2019.101376. Epub 2019 Aug 26. Mult Scler Relat Disord. 2019. PMID: 31473488
Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients.
Kürtüncü M, Yılmaz V, Akçay Hİ, Türkoğlu R, Altunrende B, Çınar SA, Ulusoy C, Gündüz T, İçöz S, Kasap M, Çalışkan Z, Ötünç G, Eraksoy M, Tüzün E. Kürtüncü M, et al. Among authors: altunrende b. J Neuroimmunol. 2019 Dec 15;337:577065. doi: 10.1016/j.jneuroim.2019.577065. Epub 2019 Sep 11. J Neuroimmunol. 2019. PMID: 31526917 Clinical Trial.
Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE).
Tuncer MA, Kürtüncü M, Terzi M, Uygunoğlu U, Göncüoğlu C, Yüceyar AN, Ekmekçi Ö, Türkoğlu R, Soysal A, Köseoğlu M, Boz C, Beckmann Y, Turan ÖF, Demirkıran DM, Akman FG, Altunrende B, Cantürk İA, Birday E, Özcan A, Kamişli Ö, Özen NPA, Çelik RGG, Balcı FB, Efendi H, Sarıkaya C, Akçalı A, Toprak MK, Kabay SC, Kızılay F, Sevim MS, Gazaloğlu GB, Demir CF, Balgetir F, Kıylıoğlu N, Sarıahmetoğlu H, Ölmez Ç, Mavi K, Yüksel S, Işık N, Saip S, Karabudak R, Siva A, Eraksoy M. Tuncer MA, et al. Among authors: altunrende b. Turk J Med Sci. 2023 Feb;53(1):323-332. doi: 10.55730/1300-0144.5588. Epub 2023 Feb 22. Turk J Med Sci. 2023. PMID: 36945929 Free PMC article.
The effect of cognitive performance on self-management behavior of multiple sclerosis patients.
Efendi H, Ünal A, Akçalı A, Altunan B, Bingöl A, Altunrende B, Köseoğlu M, Deringöl D, Uzunköprü C, Eğilmez C, Balcı FB, Akman G, Tarhan KG, Gündoğdu AA, Ertürk S, Beckmann Y. Efendi H, et al. Among authors: altunrende b. Mult Scler Relat Disord. 2022 Jul;63:103880. doi: 10.1016/j.msard.2022.103880. Epub 2022 May 19. Mult Scler Relat Disord. 2022. PMID: 35613508
Characteristics of optic neuropathy in Behçet disease.
Akdal G, Toydemir HE, Saatci AO, Uygunoğlu U, Altunrende B, Saip S, Yaman A, Keskinoğlu P, Yilmaz SG, Çelebisoy N, Bajin MS, Siva A, Akman-Demir G. Akdal G, et al. Among authors: altunrende b. Neurol Neuroimmunol Neuroinflamm. 2018 Aug 10;5(5):e490. doi: 10.1212/NXI.0000000000000490. eCollection 2018 Sep. Neurol Neuroimmunol Neuroinflamm. 2018. PMID: 30175164 Free PMC article.
Intravenous Immunoglobulin Treatment for Recurrent Optic Neuritis.
Altunrende B, Akdal G, Bajin MS, Yaman A, Kocaslan M, Nalbantoğlu M, Ertaşoğlu H, Akman G. Altunrende B, et al. Noro Psikiyatr Ars. 2019 Mar;56(1):3-6. doi: 10.5152/npa.2017.20577. Epub 2018 Nov 28. Noro Psikiyatr Ars. 2019. PMID: 30911229 Free PMC article.
Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting.
Altunan B, Ünal A, Efendi H, Köseoğlu M, Terzi M, Kotan D, Tamam Y, Boz C, Güler S, Turan ÖF, Altunrende B, Balcı FB, Turgut N, Akçalı A, Yildirim KA, Günal Dİ, Sunter G, Bingöl A. Altunan B, et al. Among authors: altunrende b. Mult Scler Relat Disord. 2023 Sep;77:104880. doi: 10.1016/j.msard.2023.104880. Epub 2023 Jul 12. Mult Scler Relat Disord. 2023. PMID: 37459716
20 results